Açıklama
Apoptosis markers in Alzheimer's disease model cells are reduced following BDMC treatment. Decreased caspase-3 activation and preserved mitochondrial membrane potential indicate anti-apoptotic activity.
Figure 5
ChartSource Paper
Bisdemethoxycurcumin inhibits oxidative stress and antagonizes Alzheimer's disease by up-regulating SIRT1.Cite This Figure
![Figure 5: Apoptosis markers in Alzheimer's disease model cells are reduced following BDMC treatment. Decreased caspase-3 activation and preserved mitochondrial membrane potential indicate anti-apoptotic activity.]() > Source: Yan Xu et al. "Bisdemethoxycurcumin inhibits oxidative stress and antagonizes Alzheimer's disea." *Brain and behavior*, 2020. PMID: [32441492](https://pubmed.ncbi.nlm.nih.gov/32441492/)
<figure> <img src="" alt="Apoptosis markers in Alzheimer's disease model cells are reduced following BDMC treatment. Decreased caspase-3 activation and preserved mitochondrial membrane potential indicate anti-apoptotic activity." /> <figcaption>Figure 5. Apoptosis markers in Alzheimer's disease model cells are reduced following BDMC treatment. Decreased caspase-3 activation and preserved mitochondrial membrane potential indicate anti-apoptotic activity.<br> Source: Yan Xu et al. "Bisdemethoxycurcumin inhibits oxidative stress and antagonizes Alzheimer's disea." <em>Brain and behavior</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32441492/">32441492</a></figcaption> </figure>